Allscripts (MDRX) Provides Response to COVID-19 Outbreak
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Allscripts response to the COVID-19 outbreak
March 18, 2020 2:41 PM EDTCompany takes additional actions to protect associates, clients and partners against COVID-19
CHICAGO--(BUSINESS WIRE)-- Allscripts (NASDAQ: MDRX) is taking several steps to further its commitment to help fight the global spread of COVID-19. The company is working closely with health agencies and governments around the world to keep abreast of changes and partnering with clients to share and enable their Allscripts solutions to help combat the spread of the virus and manage their patients.
Allscripts has made updates across each of its electronic health record... More



